Nykode Therapeutics
Clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies.
Launch date
Employees
Market cap
€167m
Enterprise valuation
€13m (Public information from Sep 2024)
Share price
NOK4.644 NYKD.OL
Company register number 990646066
Oslo Norway (HQ)
Authorizing premium user...